|
|
|
|
|
|
-
推薦指數:
|
- 內容介紹
|
Textbook of the Neurogenic Bladder
Adults and Children
Edited by: Jacques Corcos, Erik Schick
Publisher:
Taylor & Francis, A Martin Dunitz Book
ISBN: 1841842060
Pub Date: 12 FEB 2004
Type:
Hardback Book
800 pages
(Dimensions 285x214 mm)
Illustrations:
231 b+w, 8 col line figures, 55 b+w, 40 col photos and 87 tables
Bladders function superbly when muscle and nerve control are normal, since the nerves carry messages the bladder muscles to the brain informing it when the bladder is full. Generally, we have two options: either to tighten our muscles to retain the urine, or to relax the muscles and urinate. When the nerve message system is damaged, different problems present: urine may back up into the kidneys and cause renal and vascular damage; retained urine may cause infection in the bladder or ureters. The nerves can be damaged by trauma, heavy metal poisoning, diabetes and acute infections. Textbook of the Neurogenic Bladder covers all aspects of nervous bladder function from causes to treatment of both retention and incontinence. All of the contributors are world leaders whether in research, clinical or surgical practice and their expertise is clearly, succinctly written to give the reader solid grounding with this important, treatable condition.
Contents:
Part I: The Normal Urinary Tract 1. Embryology of the Lower Urinary Tract 2. Simplified Anatomy of the Vesico-urethral Unit 3. Physiology of the Smooth Muscles of the Bladder and Urethra 4. Physiology of the Striated Muscles 5. Pharmacology of the Lower Urinary Tract 6. Integrated Physiology of the Lower Urinary Tract Part II: Functional Pathology of the Lower Urinary Tract 7. Epidemiology of the Neurogenic Bladder 8. Ultrastructural Pathology of Neurogenic Bladder 9. Pathophysiology of the Overactive Bladder 10. Pathophysiology of the Areflexic Bladder 11. Pathophysiology of the Low Compliant Bladder 12. Pathophysiology of the Detrusor-sphincter Dyssynergia 13. Pathophysiology of the Autonomic Dysreflexia 14. Pathophysiology of Spinal Chord Injury Part III: Neurological Pathologies Responsible for the Development of the Neurogenic Bladder Developmental Abnormalities 15. Spina Bifida in Infancy and Childhood 16. Spina Bifida in Adults 17. Syringomyelia and Lower Urinary Tract Dysfunction Peripheral Neuropathies 18. Systemic Illnesses (Diabetes Mellitus, Sarcoidosis, Alcoholism and Porphyrias) 19. Other Peripheral Neuropathies (Lumbo-sacral Zoster, Genito-urinary Herpes, Tabes Dorsalis, Guillan-Barr?Syndrome) 20. Peripheral Neuropathies of the Lower Urinary Tract, Following Pelvic Surgery and Radiation Therapy Hereditary and Degenerative Diseases 21. Dementia and Lower Urinary Tract Dysfunction 22. Pathologies of the Basal Ganglia (Parkinson's Disease, Huntingdon's Disease) 23. Urinary Dysfunction in Multiple System Atrophy Demyelinating Neuropathies 24. Multiple Sclerosis 25. Other Diseases (Transverse Myelitis, Tropical Spastic Paraparesia, Progressive Multifocal Leuko-encephalopathy, Lyme Disease) Vascular Pathologies and Tumors of the Brain 26. Cerebrovascular Accidents, Intracranial Tumors, and its Urologic Consequences Disc Prolapse and Tumors of the Spinal Cord 27. Inverebral Disc Prolapse 28. Spinal and Cord Tumors Traumatic Injuries of the Central Nervous System 29. Spinal Cord Injury and Cerebral Trauma Other Neurological Pathologies Responsible for Neurogenic Bladder Dysfunction 30. Cerebral Palsy, Cerebellar Ataxia, AIDS, Phacomatosis, Neuromuscular Disorders and Epilepsia Part IV: Evaluation of Neurogenic Bladder Dysfunction 31. Clinical Evaluation: History and Physical Examination 32. Quality of Life Assessment in Neurogenic Bladder 33. The Voiding Diary 34. The Pad Test 35. Endoscopic Evaluation of the Neurogenic Bladder 36. Imaging Techniques in the Evaluation of Neurogenic Bladder Dysfunction 37. Normal Urodynamic Parameters in Children 38. Evaluation of Neurogenic Bladder Dysfunction: Basic Urodynamics 39. Urodynamics in Infants and Children 40. Electrophysiological Evaluation: Basic Principles and Clinical Applications 41. Practical Guide to Diagnosisand Follow-up of Patients with Neurogenic Bladder Dysfunction Part V: Classification 42. Classification of Lower Urinary Tract Dysfunction Part VI: Treatment Non-surgical 43. Conservative Treatment 44. Systemic and Intrathecal Pharmacological Treatment 45. Intravesical Pharmacological Treatment 46. Transdermal Oxybutynin Administration 47. Management of Autonomic Dysreflexia Electrical 48. Peripheral Electrical Stimulation 49. Emptying the Neurogenic Bladder by Electrical Stimulation 50. Central Neuromodulation 51. Intravesical Electrical Stimulation of the Bladder Surgical 52. Surgery to Improve Reservoir Function 53. Surgery to Improve Bladder Outlet Function 54. Urinary Diversion Future Developments 55. Tissue Engineering Applications for Patients with Neurogenic Bladder 56. Restoration of Complete Bladder Function by Neurostimulation 57. Neuroprotection and Repair Afger Spinal Cord Injury Part VII: Synthesis of Treatment 58. Treatment Alternatives for Different Types of Neurogenic Bladder Dysfunction in Adults 59. Treatment Alternatives for Different Types of Neurogenic Bladder Dysfunction in Children 60. The Vesicourethral Balance Part VIII: Complications 61. Complications Related to Neurogenic Bladder Dysfunction i. Infection, Lithiasis and Neoplasia 62. Complications Related to Neurogenic Bladder Dysfunction ii. Reflux and Renal Insufficiency Part IX: Prognosis 63. Evolution and follow-up of Lower Urinary tract dysfunction in Spinal Cord Injured Patients
Full Contributors:
Mazen Abdelhady MD, MSc, University of Toronto, Toronto, Canada
Waleed Altaweel MD, McGill University, Montreal, Quebec, Canada
Karl-Erik Andersson MD, PhD, Lund University Hospital, Lund, Sweden
Walter Artibani MD, University of Verona, Verona, Italy
Anthony Atala MD, Children's Hospital and Harvard Medical School, Boston, USA
Greg G Bailly MD, FRCSC, University of Toronto, Toronto, Ontario, Canada
Diego Barrieras MD, FRCSC, University of Montreal, Ste-Justine Hospital for Children, Montreal, Canada
Pierre E Bertrand MD, FRCSC, University of Montreal, Maisonneuve-Rosemont Hospital, Montreal, Canada
Jerry G Blaivas MD, Cornell University, and Lenox Hill Hospital, New York, USA
Bertil FM Blok MD, PhD, University of Amsterdam, The Netherlands
Timothy B Boone MD, PhD, Baylor College of Medicine, Houston, USA
Ruud JLH Bosch MD, PhD, Erasmus Medical Centre, Rotterdam, The Netherlands
Alison F Brading MA(Oxon), PhD, MSc, Oxford University, Oxford, UK
Andrew Z Buczynski MD, PhD, Metropolitan Rehabilitation Center, Konstancin/Warsaw, Poland
Maria Angela Cerruto MD, Resident in Urology, University of Verona, Verona, Italy
Michael B Chancellor MD, University of Pittsburgh Medical Center, Pittsburgh, USA
Emmanuel Chartier-Kastler MD PhD, Groupe Hospitalier Piti?Salp彋ri鋨e, Paris, France
Jacques Corcos MD FRCSC, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
Michael Craggs, Royal National Orthopaedic Hospital, Stanmore, Middlesex, UK
Graham H. Creasey MD FRCSEd, Case Western Reserve University, Cleveland, USA
Francisco Cruz MD PhD, Hospital de S. Jo緌, Porto, Portugal
Willy G Davila MD, Cleveland Clinic Florida, Weston, USA
Gina Defreitas MD, University of Texas Southwestern Medicine School, Dallas, USA
Pierre Denys MD, Raymond-Poincar?Hospital, Garches, France
Dalton W Dietrich PhD, University of Miami School of Medicine, Miami, USA
Ananias C Diokno MD, William Beaumont Hospital, Royal Oak, USA
Marcus J Drake DM MA FRCS, The Medical School, University of Newcastle, Newcastle upon Tyne, UK
Ahmad Elbadawi MD, Upstate Medical University, Syracuse, USA
Nader Elmayergi MD, University of Toronto, Canada
Magnus Fall MD PhD, Sahlgrenska University Hospital, University of G飆eborg, Sweden
Adam J Flisser MD, Cornell University, New York, USA
Clare J Fowler MBBS MSc FRCP, The National Hospital for Neurology and Neurosurgery, London, UK
|
|
|